These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7496287)
1. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. Impallomeni M; Galletly NP; Wort SJ; Starr JM; Rogers TR BMJ; 1995 Nov; 311(7016):1345-6. PubMed ID: 7496287 [No Abstract] [Full Text] [Related]
2. Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Cefotaxime compares favourably with other third generation cephalosporins. Rothschild E; Rauss A; Danan G BMJ; 1996 Mar; 312(7033):778. PubMed ID: 8605486 [No Abstract] [Full Text] [Related]
3. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Settle CD; Wilcox MH; Fawley WN; Corrado OJ; Hawkey PM Aliment Pharmacol Ther; 1998 Dec; 12(12):1217-23. PubMed ID: 9882029 [TBL] [Abstract][Full Text] [Related]
4. Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Mortality due to C difficile colitis in elderly people has been underestimated. Lesna M; Parham DM BMJ; 1996 Mar; 312(7033):778. PubMed ID: 8605487 [No Abstract] [Full Text] [Related]
5. Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly. Starr JM; Impallomeni M Biomed Pharmacother; 1997; 51(2):63-7. PubMed ID: 9161469 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of antibiotic prophylaxis in critically ill patients. Antibiotic prophylaxis can lead to contamination with Clostridium difficile. Leung D BMJ; 1998 Nov; 317(7171):1527. PubMed ID: 9882129 [No Abstract] [Full Text] [Related]
12. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea? Blondeau JM J Antimicrob Chemother; 2009 Feb; 63(2):238-42. PubMed ID: 19028718 [TBL] [Abstract][Full Text] [Related]
15. Community-acquired toxigenic Clostridium difficile diarrhoea in the normoxaemic elderly who have received no antimicrobials: soft evidence for ischaemic colitis? Laing RB; Dykhuizen RS; Smith CC; Gould IW; Reid TM Scott Med J; 1996 Feb; 41(1):15-6. PubMed ID: 8658116 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and treatment of Clostridium difficile infection. Tonna I; Welsby PD Postgrad Med J; 2005 Jun; 81(956):367-9. PubMed ID: 15937201 [TBL] [Abstract][Full Text] [Related]
17. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Bauer MP; Goorhuis A; Koster T; Numan-Ruberg SC; Hagen EC; Debast SB; Kuijper EJ; van Dissel JT Neth J Med; 2008 May; 66(5):207-11. PubMed ID: 18490799 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic-associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile. A review of 40 cases. Miller SD; Blake M; Miliotis M; Still C; Taubin A; Koornhof HJ S Afr Med J; 1983 Jun; 63(24):936-9. PubMed ID: 6857419 [TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease. Patel NS BJU Int; 2007 Jun; 99(6):1333-4. PubMed ID: 17233799 [No Abstract] [Full Text] [Related]
20. Clostridium difficile-associated diarrhea in a pediatric hospital. Spivack JG; Eppes SC; Klein JD Clin Pediatr (Phila); 2003 May; 42(4):347-52. PubMed ID: 12800729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]